PDF
Update on Immunization in Pregnancy with Tetanus Toxoid, Reduced Diphtheria Toxoid and Reduced Acellular Pertussis (Tdap) Vaccine
Organization: Public Health Agency of Canada (PHAC)Published: 2018
"...in view of the low number of severe outcomes in newborns being observed in Canada, as well as the uncertainty about the potentially adverse effects of maternally derived antibodies on lowering the infant’s response to immunization with diphtheria and tetanus toxoids, acellular pertussis (DTaP) vaccine, routine immunization with Tdap vaccine in pregnancy was not recommended at that time. With the availability of new effectiveness data reported following the implementation of routine maternal immunization programs internationally, the NACI Diphtheria/Tetanus/Pertussis/Polio/Haemophilus Influenza B Working Group (PWG) was again tasked with reviewing the evidence pertaining to the use of Tdap vaccine in pregnancy. In accordance with the direction that was provided by the Canadian Immunization Committee, the objective of this NACI Statement is to provide guidance on maternal immunization in pregnancy as a strategy to reduce disease incidence and severe outcomes (defined as hospitalization or death) from pertussis infection in infants less than 12 months of age". - Update on Immunization in Pregnancy with Tetanus Toxoid, Reduced Diphtheria Toxoid and Reduced Acellular Pertussis (Tdap) Vaccine
Product Type: Report
Category:
Specific Populations,Adults,Pregnant and Breastfeeding People,Vaccine Preventable Diseases,Communicable Diseases,Tetanus (Lockjaw),Diphtheria,Pertussis (Whooping Cough) Specific PopulationsAdults
Pregnant and Breastfeeding People
Vaccine Preventable Diseases
Communicable Diseases
Tetanus (Lockjaw)
Diphtheria
Pertussis (Whooping Cough)
LinkResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.